82 related articles for article (PubMed ID: 1534767)
1. Quisqualate neurotoxicity in rat cortical cultures: pharmacology and mechanisms.
Zinkand WC; DeFeo PA; Thompson C; Hargrove H; Salama AI; Patel J
Eur J Pharmacol; 1992 Mar; 212(2-3):129-36. PubMed ID: 1534767
[TBL] [Abstract][Full Text] [Related]
2. 6,7-Dinitroquinoxaline-2,3-dione blocks the cytotoxicity of N-methyl-D-aspartate and kainate, but not quisqualate, in cortical cultures.
Patel J; Zinkand WC; Klika AB; Mangano TJ; Keith RA; Salama AI
J Neurochem; 1990 Jul; 55(1):114-21. PubMed ID: 2162373
[TBL] [Abstract][Full Text] [Related]
3. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia.
Nellgård B; Wieloch T
J Cereb Blood Flow Metab; 1992 Jan; 12(1):2-11. PubMed ID: 1345757
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of brain to AMPA induced excitotoxicity transiently peaks during early postnatal development.
McDonald JW; Trescher WH; Johnston MV
Brain Res; 1992 Jun; 583(1-2):54-70. PubMed ID: 1380402
[TBL] [Abstract][Full Text] [Related]
5. Non-NMDA receptor-mediated neurotoxicity in cortical culture.
Koh JY; Goldberg MP; Hartley DM; Choi DW
J Neurosci; 1990 Feb; 10(2):693-705. PubMed ID: 2406381
[TBL] [Abstract][Full Text] [Related]
6. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia.
Sheardown MJ; Nielsen EO; Hansen AJ; Jacobsen P; Honoré T
Science; 1990 Feb; 247(4942):571-4. PubMed ID: 2154034
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Ca2(+)-mobilizing excitatory amino acid receptors in cultured chick cortical cells.
McMillian M; Pritchard GA; Miller LG
Eur J Pharmacol; 1990 Oct; 189(4-5):253-66. PubMed ID: 1980647
[TBL] [Abstract][Full Text] [Related]
8. Neuronal damage induced by beta-N-oxalylamino-L-alanine, in the rat hippocampus, can be prevented by a non-NMDA antagonist, 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline.
Willis CL; Meldrum BS; Nunn PB; Anderton BH; Leigh PN
Brain Res; 1993 Nov; 627(1):55-62. PubMed ID: 7507397
[TBL] [Abstract][Full Text] [Related]
9. Neurotoxicity of acute glutamate transport blockade depends on coactivation of both NMDA and AMPA/Kainate receptors in organotypic hippocampal cultures.
Vornov JJ; Tasker RC; Park J
Exp Neurol; 1995 May; 133(1):7-17. PubMed ID: 7541369
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of NBQX on the distal and local toxicity of glutamate agonists administered intra-hippocampally.
Lees GJ; Leong W
Brain Res; 1993 Nov; 628(1-2):1-7. PubMed ID: 7508807
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of noradrenaline release in human cerebral cortex mediated by N-methyl-D-aspartate (NMDA) and non-NMDA receptors.
Fink K; Schultheiss R; Göthert M
Br J Pharmacol; 1992 May; 106(1):67-72. PubMed ID: 1380384
[TBL] [Abstract][Full Text] [Related]
12. Excitatory amino acid receptor-stimulated phosphoinositide turnover in primary cerebrocortical cultures.
Birrell GJ; Marcoux FW
Br J Pharmacol; 1993 Jun; 109(2):379-85. PubMed ID: 8395285
[TBL] [Abstract][Full Text] [Related]
13. Effects of decahydroisoquinoline-3-carboxylic acid monohydrate, a novel AMPA receptor antagonist, on glutamate-induced CA2+ responses and neurotoxicity in rat cortical and cerebellar granule neurons.
Liljequist S; Cebers G; Kalda A
Biochem Pharmacol; 1995 Nov; 50(11):1761-74. PubMed ID: 8615854
[TBL] [Abstract][Full Text] [Related]
14. The neuroprotective properties of ifenprodil, a novel NMDA receptor antagonist, in neuronal cell culture toxicity studies.
Graham D; Darles G; Langer SZ
Eur J Pharmacol; 1992 Aug; 226(4):373-6. PubMed ID: 1356814
[TBL] [Abstract][Full Text] [Related]
15. New quinoxalinediones show potent antagonism of quisqualate responses in cultured mouse cortical neurons.
Drejer J; Honoré T
Neurosci Lett; 1988 Apr; 87(1-2):104-8. PubMed ID: 2837683
[TBL] [Abstract][Full Text] [Related]
16. Mobilization of dantrolene-sensitive intracellular calcium pools is involved in the cytotoxicity induced by quisqualate and N-methyl-D-aspartate but not by 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionate and kainate in cultured cerebral cortical neurons.
Frandsen A; Schousboe A
Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2590-4. PubMed ID: 1372982
[TBL] [Abstract][Full Text] [Related]
17. Involvement of AMPA/kainate-excitotoxicity in MK801-induced neuronal death in the retrosplenial cortex.
Bender C; Rassetto M; de Olmos JS; de Olmos S; Lorenzo A
Neuroscience; 2010 Aug; 169(2):720-32. PubMed ID: 20457221
[TBL] [Abstract][Full Text] [Related]
18. AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h.
Sheardown MJ; Suzdak PD; Nordholm L
Eur J Pharmacol; 1993 Jun; 236(3):347-53. PubMed ID: 7689464
[TBL] [Abstract][Full Text] [Related]
19. Selective stimulation of excitatory amino acid receptor subtypes and the survival of granule cells in culture: effect of quisqualate and AMPA.
Hack N; Balázs R
Neurochem Int; 1994 Sep; 25(3):235-41. PubMed ID: 7530540
[TBL] [Abstract][Full Text] [Related]
20. Systemic excitatory amino acid receptor antagonists of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor and of the N-methyl-D-aspartate (NMDA) receptor relieve mechanical hypersensitivity after transient spinal cord ischemia in rats.
Xu XJ; Hao JX; Seiger A; Wiesenfeld-Hallin Z
J Pharmacol Exp Ther; 1993 Oct; 267(1):140-4. PubMed ID: 8229741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
